期刊文献+

自身免疫性肝病的诊断及治疗进展 被引量:1

Advances in the Diagnosis and Treatment of Autoimmune Liver Disease
下载PDF
导出
摘要 自身免疫性肝病是机体免疫系统对自身组织的抗原丧失免疫耐受,从而导致了以肝脏为相对特异性免疫病理损伤器官的一类自身免疫性疾病,其病因及发病机制尚不完全清楚,可能与遗传易患性和环境因素有关。近年来,随着对自身免疫性肝病认识水平的提高以及自身抗体检测方法的不断改进,一些学者在自身免疫性肝病的诊治方面提出了一些见解,目前该疾病的诊断主要依赖于血清中自身抗体的检测和临床表现,对于治疗目前自身免疫性肝炎采用免疫抑制剂和皮质激素治疗,原发性胆汁性肝硬化和原发性硬化性胆管炎采用熊去氧胆酸和皮质激素治疗,对于终末期建议采用肝移植治疗。 Autoimmune liver disease is an autoimmune disease with relatively specific pathological injury of liver, because of loss of immune tolerance to self-antigens, and its etiology and pathogenesis are not fully clear, which may be associated with genetic susceptibility and environmental factors. In recent years, with the improvement of understanding of autoimmune liver disease as well as the level of autoantibody detection, a number of scholars present some insights in the diagnosis and treatment of autoimmune liver disease. At present, the diagnosis of this disease relies on the detection of autoantibodies in serum and clinical manifestations, and the treatment of autoimmune hepatitis often adopts immunosuppressants and corticosteroids, while primary biliary cirrhosis and primary sclerosing often adopt ursodeoxycholic acid and corticosteroids, and transplantation of liver is recommended for the end-stage patients.
出处 《医学综述》 2014年第13期2339-2341,共3页 Medical Recapitulate
关键词 自身免疫性肝病 诊断 治疗 Autoimmune liver disease Diagnosis Treatment
  • 相关文献

参考文献10

二级参考文献103

  • 1尚祥武,邓方阁,邓秀芳.自身免疫性肝炎的发病、分型及与其相关的自身免疫性肝病[J].临床肝胆病杂志,2007,23(3):221-223. 被引量:2
  • 2陈嵩,王宇明.自身免疫重叠综合征[J].世界华人消化杂志,2005,13(15):1875-1878. 被引量:7
  • 3林菊生,梁扩寰.自身免疫性肝病临床诊治进展[J].交通医学,2006,20(3):237-240. 被引量:5
  • 4Grimbert S, Johanet C, Bendjaballah F, et al. Antimitochondrial antibodiesin patients with chronic hepatitis C [J]. Liver, 1996, 16(3) :161 - 165.
  • 5Leung PS, Rossaro L, Davis PA, et al. Antimitochondrial antibodies inacute liver failure : implications for primary biliary cirrhosis [ J ]. Hepatology,2007, 46 (5) : 1436 - 1442.
  • 6PARES A, CABALLERIA L, RODES J. Excellent long2term survival in patientswith primary biliary cirrhosis and biochemical response to ur2 sodeoxycholic aid [ J ]. Gastroenterology, 2006, 130 (3) : 7151.
  • 7CORPECHOT C, ABENAVOL I L, RABAHI N, et al. Biochemical re2 sponse to ursodeoxycholic acid and long2term prognosis in primary bili2 ary cirrhosis [ J ]. Hepatology, 2008, 48 ( 3 ) 8711.
  • 8RAUTIAINEN H, KARKKAINEN P, KARVONEN AL, et al. Bu2desonide combined withUDCA to improve liver histology in primary biliary cirrho2 sIs:A three-year randomized trial [ J ]. Hepatology, 2005, 41 (4) : 7471.
  • 9Heathcote EJ. Management of primary biliary cirrhosis[ J]. Hepatology, 2000, 31 : 1005 - 1013.
  • 10Lindor KD,Kowdley KV,Luketic VA, et al. High - dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis [ J]. Hepatology, 2009,50(3 ) : 808 - 814.

共引文献70

同被引文献14

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部